enVVeno Medical Corporation
NVNO
$4.87
$0.265.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -2.20% | -3.37% | 29.79% | 1.12% | -23.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.98% | 6.71% | 15.35% | -19.96% | -19.04% |
| Operating Income | 9.98% | -6.71% | -15.35% | 19.96% | 19.04% |
| Income Before Tax | 9.80% | -10.27% | -12.82% | 23.45% | 21.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 9.80% | -10.27% | -12.82% | 23.45% | 21.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.80% | -10.27% | -12.82% | 23.45% | 21.90% |
| EBIT | 9.98% | -6.71% | -15.35% | 19.96% | 19.04% |
| EBITDA | 9.80% | -7.01% | -15.76% | 20.06% | 19.21% |
| EPS Basic | 28.82% | 16.06% | 21.13% | 45.60% | 53.93% |
| Normalized Basic EPS | 31.38% | 20.09% | 19.92% | 43.56% | 52.44% |
| EPS Diluted | 28.82% | 16.06% | 21.13% | 45.60% | 53.93% |
| Normalized Diluted EPS | 31.38% | 20.09% | 19.92% | 43.56% | 52.44% |
| Average Basic Shares Outstanding | 26.75% | 31.38% | 43.06% | 40.73% | 69.52% |
| Average Diluted Shares Outstanding | 26.75% | 31.38% | 43.06% | 40.73% | 69.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |